The family physician and designer drugs
Mendive, J.M.
Atencion Primaria 21(3): 180-181
1998
ISSN/ISBN: 0212-6567 PMID: 9607239 Document Number: 491643
Document emailed within 1 workday
Related Documents
Naito, H. 2010: Entactogen and designer drugs (2) Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 23(2): 97-104Henderson, F.; Kenny, G.N. 1999: Controversies in anaesthesia--designer drugs Annals of the Academy of Medicine Singapore 28(3): 434-439
Henderson, G.L. 1988: Designer drugs: past history and future prospects Journal of Forensic Sciences 33(2): 569-575
Misselbrook, G.P.; Hamilton, E.J. 2012: Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs Acute Medicine 11(3): 157-160
Wierzejska, R. 2014: Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism Developmental Period Medicine 18(3): 394-399
Vink-Stephan, J.J. 1988: The stability of drugs with special attention to the doctor's bag and the apothecary of the family physician Nederlands Tijdschrift Voor Geneeskunde 132(18): 804-806
Farre Albaladejo, M. 1989: Neurologic complications of drug addiction. General aspects. Complications caused by cannabis, designer drugs and volatile substances Archivos de Neurobiologia 52(Suppl 1): 143-148
Rodríguez Arenas, M.A.; Barrio Anta, G.; de la Fuente de Hoz, L.; Royuela, L. 1997: Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants Revista Clinica Espanola 197(12): 804-809
Bullock, D.; Thompson, B. 1979: Guidelines for family interviewing and brief therapy by the family physician Journal of Family Practice 9(5): 837-841
van Wijngaarden, D.A. 1995: Hypertension diagnosis by the family physician: measurements according to the NHG-standard (Dutch College of Family Physicians) compared to ambulatory blood pressure determination Nederlands Tijdschrift Voor Geneeskunde 139(17): 901-902
Alvarez-Bravo, A. 1974: Family planning in Mexico at the present time. I. Attitude of the physician with respect to family planning Gaceta Medica de Mexico 107(1): 7-11
Alvarez-Bravo, A. 1974: Family planning in Mexico at the present time. I. the attitude of the physician in family planning Gaceta Medica de Mexico 107(1): 7-11
Ekholm, M-Louise. 2004: It's the patient who suffers when physician's knowledge of drugs is not sufficient Lakartidningen 101(45): 3620
Badellino, F. 1980: A new family physician Minerva Chirurgica 35(18 Suppl): 25-26
Von Schrader-Beielstein, A. 2000: Travel pharmaceuticals for the physician. 3: Additional drugs for diving and trekking MMW Fortschritte der Medizin 142(22): 46-48
Kunz, R.; Leuthold, A.; Buddeberg, C. 1998: Sexual dysfunctions with antidepressive drugs--results of a physician survey Praxis 87(18): 610-616
Nuñez-López, J.A. 1983: Use of psychoactive drugs by the primary care physician. General principles Boletin de la Asociacion Medica de Puerto Rico 75(6): 284-287
Taylor, R.B. 1987: FP means family physician Family Medicine 19(3): 172-173
Mehrle, G. 1999: The ophthalmologist, family physician for the eye? Klinische Monatsblatter für Augenheilkunde 214(5): Aa9
Stock Keister, M.C.; Green, L.A.; Kahn, N.B.; Phillips, R.L.; McCann, J.; Fryer, G.E. 2004: What people want from their family physician American Family Physician 69(10): 2310